Pre-order Enquiry
Request Free Sample
Global Platinum-based Anticancer Drugs Market Growth 2021-2026
SKU ID : LPI-18517041 | Publishing Date : 20-Apr-2021 | No. of pages : 165
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Platinum-based Anticancer Drugs Market Growth 2021-2026
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Platinum-based Anticancer Drugs Consumption 2016-2026
2.1.2 Platinum-based Anticancer Drugs Consumption CAGR by Region
2.2 Platinum-based Anticancer Drugs Segment by Type
2.2.1 Cisplatin
2.2.2 Carboplatin
2.2.3 Oxaliplatin
2.2.4 Nedaplatin
2.2.5 Others
2.3 Platinum-based Anticancer Drugs Sales by Type
2.3.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Platinum-based Anticancer Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Platinum-based Anticancer Drugs Sale Price by Type (2016-2021)
2.4 Platinum-based Anticancer Drugs Segment by Application
2.4.1 Testicular Cancer
2.4.2 Osteosarcoma
2.4.3 Breast Cancer
2.4.4 Esophageal Cancer
2.4.5 NSCLC
2.4.6 Other
2.5 Platinum-based Anticancer Drugs Sales by Application
2.5.1 Global Platinum-based Anticancer Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Platinum-based Anticancer Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Platinum-based Anticancer Drugs Sale Price by Application (2016-2021)
3 Global Platinum-based Anticancer Drugs by Company
3.1 Global Platinum-based Anticancer Drugs Sales Market Share by Company
3.1.1 Global Platinum-based Anticancer Drugs Sales by Company (2019-2021)
3.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Company (2019-2021)
3.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Company
3.2.1 Global Platinum-based Anticancer Drugs Revenue by Company (2019-2021)
3.2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Platinum-based Anticancer Drugs Sale Price by Company
3.4 Global Manufacturers Platinum-based Anticancer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Platinum-based Anticancer Drugs Product Location Distribution
3.4.2 Players Platinum-based Anticancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Platinum-based Anticancer Drugs by Region
4.1 Global Platinum-based Anticancer Drugs by Region
4.1.1 Global Platinum-based Anticancer Drugs Sales by Region
4.1.2 Global Platinum-based Anticancer Drugs Revenue by Region
4.2 Americas Platinum-based Anticancer Drugs Sales Growth
4.3 APAC Platinum-based Anticancer Drugs Sales Growth
4.4 Europe Platinum-based Anticancer Drugs Sales Growth
4.5 Middle East & Africa Platinum-based Anticancer Drugs Sales Growth
5 Americas
5.1 Americas Platinum-based Anticancer Drugs Sales by Country
5.1.1 Americas Platinum-based Anticancer Drugs Sales by Country (2016-2021)
5.1.2 Americas Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
5.2 Americas Platinum-based Anticancer Drugs Sales by Type
5.3 Americas Platinum-based Anticancer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Platinum-based Anticancer Drugs Sales by Region
6.1.1 APAC Platinum-based Anticancer Drugs Sales by Region (2016-2021)
6.1.2 APAC Platinum-based Anticancer Drugs Revenue by Region (2016-2021)
6.2 APAC Platinum-based Anticancer Drugs Sales by Type
6.3 APAC Platinum-based Anticancer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Platinum-based Anticancer Drugs by Country
7.1.1 Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021)
7.1.2 Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
7.2 Europe Platinum-based Anticancer Drugs Sales by Type
7.3 Europe Platinum-based Anticancer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Platinum-based Anticancer Drugs by Country
8.1.1 Middle East & Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Platinum-based Anticancer Drugs Sales by Type
8.3 Middle East & Africa Platinum-based Anticancer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Platinum-based Anticancer Drugs Distributors
10.3 Platinum-based Anticancer Drugs Customer
11 Global Platinum-based Anticancer Drugs Market Forecast
11.1 Global Platinum-based Anticancer Drugs Forecast by Region
11.1.1 Global Platinum-based Anticancer Drugs Forecast by Regions (2021-2026)
11.2.2 Global Platinum-based Anticancer Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Platinum-based Anticancer Drugs Forecast by Type
11.7 Global Platinum-based Anticancer Drugs Forecast by Application
12 Key Players Analysis
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Company Information
12.1.2 Sanofi-Aventis Platinum-based Anticancer Drugs Product Offered
12.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sanofi-Aventis Main Business Overview
12.1.5 Sanofi-Aventis Latest Developments
12.2 Yakult honsha
12.2.1 Yakult honsha Company Information
12.2.2 Yakult honsha Platinum-based Anticancer Drugs Product Offered
12.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Yakult honsha Main Business Overview
12.2.5 Yakult honsha Latest Developments
12.3 Dr Reddy's laboratories
12.3.1 Dr Reddy's laboratories Company Information
12.3.2 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offered
12.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Dr Reddy's laboratories Main Business Overview
12.3.5 Dr Reddy's laboratories Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Information
12.4.2 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offered
12.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sun Pharmaceutical Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Teva
12.5.1 Teva Company Information
12.5.2 Teva Platinum-based Anticancer Drugs Product Offered
12.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Teva Main Business Overview
12.5.5 Teva Latest Developments
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Company Information
12.6.2 Fresenius Kabi Platinum-based Anticancer Drugs Product Offered
12.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Fresenius Kabi Main Business Overview
12.6.5 Fresenius Kabi Latest Developments
12.7 Hospira(Pfizer)
12.7.1 Hospira(Pfizer) Company Information
12.7.2 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offered
12.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hospira(Pfizer) Main Business Overview
12.7.5 Hospira(Pfizer) Latest Developments
12.8 Mylan
12.8.1 Mylan Company Information
12.8.2 Mylan Platinum-based Anticancer Drugs Product Offered
12.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Mylan Main Business Overview
12.8.5 Mylan Latest Developments
12.9 Taj Pharmaceuticals
12.9.1 Taj Pharmaceuticals Company Information
12.9.2 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offered
12.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Taj Pharmaceuticals Main Business Overview
12.9.5 Taj Pharmaceuticals Latest Developments
12.10 Jiangsu Hengrui Medicine
12.10.1 Jiangsu Hengrui Medicine Company Information
12.10.2 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offered
12.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Jiangsu Hengrui Medicine Main Business Overview
12.10.5 Jiangsu Hengrui Medicine Latest Developments
12.11 Nanjing Pharmaceutical Factory
12.11.1 Nanjing Pharmaceutical Factory Company Information
12.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offered
12.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Nanjing Pharmaceutical Factory Main Business Overview
12.11.5 Nanjing Pharmaceutical Factory Latest Developments
12.12 Jiangsu Aosaikang Pharmaceutical
12.12.1 Jiangsu Aosaikang Pharmaceutical Company Information
12.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offered
12.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
12.12.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
12.13 Qilu Pharmaceutical
12.13.1 Qilu Pharmaceutical Company Information
12.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offered
12.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Qilu Pharmaceutical Main Business Overview
12.13.5 Qilu Pharmaceutical Latest Developments
12.14 Hisun Pharmaceutical
12.14.1 Hisun Pharmaceutical Company Information
12.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offered
12.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Hisun Pharmaceutical Main Business Overview
12.14.5 Hisun Pharmaceutical Latest Developments
12.15 Luoxin
12.15.1 Luoxin Company Information
12.15.2 Luoxin Platinum-based Anticancer Drugs Product Offered
12.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Luoxin Main Business Overview
12.15.5 Luoxin Latest Developments
12.16 Lingnan Pharmacy
12.16.1 Lingnan Pharmacy Company Information
12.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offered
12.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Lingnan Pharmacy Main Business Overview
12.16.5 Lingnan Pharmacy Latest Developments
12.17 Hansoh Pharma
12.17.1 Hansoh Pharma Company Information
12.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Product Offered
12.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Hansoh Pharma Main Business Overview
12.17.5 Hansoh Pharma Latest Developments
13 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global Platinum-based Anticancer Drugs Market Growth 2021-2026
List of TablesTable 1. Platinum-based Anticancer Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Cisplatin
Table 3. Major Players of Carboplatin
Table 4. Major Players of Oxaliplatin
Table 5. Major Players of Nedaplatin
Table 6. Major Players of Others
Table 7. Global Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)
Table 8. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
Table 9. Global Platinum-based Anticancer Drugs Revenue by Type (2016-2021) & ($ million)
Table 10. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)
Table 11. Global Platinum-based Anticancer Drugs Sale Price by Type (2016-2021)
Table 12. Global Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)
Table 13. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Table 14. Global Platinum-based Anticancer Drugs Value by Application (2016-2021)
Table 15. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2016-2021)
Table 16. Global Platinum-based Anticancer Drugs Sale Price by Application (2016-2021)
Table 17. Global Platinum-based Anticancer Drugs Sales by Company (2019-2021) & (K Units)
Table 18. Global Platinum-based Anticancer Drugs Sales Market Share by Company (2019-2021)
Table 19. Global Platinum-based Anticancer Drugs Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2019-2021)
Table 21. Global Platinum-based Anticancer Drugs Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Platinum-based Anticancer Drugs Producing Area Distribution and Sales Area
Table 23. Players Platinum-based Anticancer Drugs Products Offered
Table 24. Platinum-based Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Platinum-based Anticancer Drugs Sales by Region (2016-2021) (K Units)
Table 28. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)
Table 29. Global Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)
Table 31. Americas Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 32. Americas Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 33. Americas Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 35. Americas Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)
Table 36. Americas Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
Table 37. Americas Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)
Table 38. Americas Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Table 39. APAC Platinum-based Anticancer Drugs Sales by Region (2016-2021) & (K Units)
Table 40. APAC Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)
Table 41. APAC Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)
Table 43. APAC Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)
Table 44. APAC Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
Table 45. APAC Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)
Table 46. APAC Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Table 47. Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 48. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 49. Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 51. Europe Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)
Table 52. Europe Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
Table 53. Europe Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)
Table 54. Europe Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Platinum-based Anticancer Drugs
Table 64. Key Application and Potential Industries of Platinum-based Anticancer Drugs
Table 65. Key Challenges of Platinum-based Anticancer Drugs
Table 66. Key Trends of Platinum-based Anticancer Drugs
Table 67. Platinum-based Anticancer Drugs Distributors List
Table 68. Platinum-based Anticancer Drugs Customer List
Table 69. Global Platinum-based Anticancer Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Platinum-based Anticancer Drugs Consumption Market Forecast by Region
Table 71. Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Platinum-based Anticancer Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Platinum-based Anticancer Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Platinum-based Anticancer Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Platinum-based Anticancer Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Platinum-based Anticancer Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Platinum-based Anticancer Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Platinum-based Anticancer Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Platinum-based Anticancer Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Platinum-based Anticancer Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Platinum-based Anticancer Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Platinum-based Anticancer Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Platinum-based Anticancer Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 89. Sanofi-Aventis Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi-Aventis Platinum-based Anticancer Drugs Product Offered
Table 91. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. Sanofi-Aventis Main Business
Table 93. Sanofi-Aventis Latest Developments
Table 94. Yakult honsha Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Yakult honsha Platinum-based Anticancer Drugs Product Offered
Table 96. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Yakult honsha Main Business
Table 98. Yakult honsha Latest Developments
Table 99. Dr Reddy's laboratories Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offered
Table 101. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Dr Reddy's laboratories Main Business
Table 103. Dr Reddy's laboratories Latest Developments
Table 104. Sun Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offered
Table 106. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Sun Pharmaceutical Main Business
Table 108. Sun Pharmaceutical Latest Developments
Table 109. Teva Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Teva Platinum-based Anticancer Drugs Product Offered
Table 111. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Teva Main Business
Table 113. Teva Latest Developments
Table 114. Fresenius Kabi Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Fresenius Kabi Platinum-based Anticancer Drugs Product Offered
Table 116. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Fresenius Kabi Main Business
Table 118. Fresenius Kabi Latest Developments
Table 119. Hospira(Pfizer) Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offered
Table 121. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Hospira(Pfizer) Main Business
Table 123. Hospira(Pfizer) Latest Developments
Table 124. Mylan Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Mylan Platinum-based Anticancer Drugs Product Offered
Table 126. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 127. Mylan Main Business
Table 128. Mylan Latest Developments
Table 129. Taj Pharmaceuticals Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offered
Table 131. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 132. Taj Pharmaceuticals Main Business
Table 133. Taj Pharmaceuticals Latest Developments
Table 134. Jiangsu Hengrui Medicine Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offered
Table 136. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 137. Jiangsu Hengrui Medicine Main Business
Table 138. Jiangsu Hengrui Medicine Latest Developments
Table 139. Nanjing Pharmaceutical Factory Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offered
Table 141. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 142. Nanjing Pharmaceutical Factory Main Business
Table 143. Nanjing Pharmaceutical Factory Latest Developments
Table 144. Jiangsu Aosaikang Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offered
Table 146. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 147. Jiangsu Aosaikang Pharmaceutical Main Business
Table 148. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 149. Qilu Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offered
Table 151. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 152. Qilu Pharmaceutical Main Business
Table 153. Qilu Pharmaceutical Latest Developments
Table 154. Hisun Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offered
Table 156. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 157. Hisun Pharmaceutical Main Business
Table 158. Hisun Pharmaceutical Latest Developments
Table 159. Luoxin Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Luoxin Platinum-based Anticancer Drugs Product Offered
Table 161. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 162. Luoxin Main Business
Table 163. Luoxin Latest Developments
Table 164. Lingnan Pharmacy Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 165. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offered
Table 166. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 167. Lingnan Pharmacy Main Business
Table 168. Lingnan Pharmacy Latest Developments
Table 169. Hansoh Pharma Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 170. Hansoh Pharma Platinum-based Anticancer Drugs Product Offered
Table 171. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 172. Hansoh Pharma Main Business
Table 173. Hansoh Pharma Latest Developments
List of Figures
Figure 1. Picture of Platinum-based Anticancer Drugs
Figure 2. Platinum-based Anticancer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Platinum-based Anticancer Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Platinum-based Anticancer Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Platinum-based Anticancer Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Cisplatin
Figure 10. Product Picture of Carboplatin
Figure 11. Product Picture of Oxaliplatin
Figure 12. Product Picture of Nedaplatin
Figure 13. Product Picture of Others
Figure 14. Global Platinum-based Anticancer Drugs Sales Market Share by Type in 2020
Figure 15. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Platinum-based Anticancer Drugs Consumed in Testicular Cancer
Figure 17. Global Platinum-based Anticancer Drugs Market: Testicular Cancer (2016-2021) & (K Units)
Figure 18. Platinum-based Anticancer Drugs Consumed in Osteosarcoma
Figure 19. Global Platinum-based Anticancer Drugs Market: Osteosarcoma (2016-2021) & (K Units)
Figure 20. Platinum-based Anticancer Drugs Consumed in Breast Cancer
Figure 21. Global Platinum-based Anticancer Drugs Market: Breast Cancer (2016-2021) & (K Units)
Figure 22. Platinum-based Anticancer Drugs Consumed in Esophageal Cancer
Figure 23. Global Platinum-based Anticancer Drugs Market: Esophageal Cancer (2016-2021) & (K Units)
Figure 24. Platinum-based Anticancer Drugs Consumed in NSCLC
Figure 25. Global Platinum-based Anticancer Drugs Market: NSCLC (2016-2021) & (K Units)
Figure 26. Platinum-based Anticancer Drugs Consumed in Other
Figure 27. Global Platinum-based Anticancer Drugs Market: Other (2016-2021) & (K Units)
Figure 28. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Figure 29. Global Platinum-based Anticancer Drugs Revenue Market Share by Application in 2020
Figure 30. Platinum-based Anticancer Drugs Revenue Market by Company in 2020 ($ Million)
Figure 31. Global Platinum-based Anticancer Drugs Revenue Market Share by Company in 2020
Figure 32. Global Platinum-based Anticancer Drugs Sales Market Share by Regions (2016-2021)
Figure 33. Global Platinum-based Anticancer Drugs Revenue Market Share by Region in 2020
Figure 34. Americas Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)
Figure 35. Americas Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)
Figure 36. APAC Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)
Figure 37. APAC Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)
Figure 38. Europe Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)
Figure 39. Europe Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)
Figure 40. Middle East & Africa Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)
Figure 41. Middle East & Africa Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)
Figure 42. Americas Platinum-based Anticancer Drugs Sales Market Share by Country in 2020
Figure 43. Americas Platinum-based Anticancer Drugs Revenue Market Share by Country in 2020
Figure 44. Americas Platinum-based Anticancer Drugs Sales Market Share by Type in 2020
Figure 45. Americas Platinum-based Anticancer Drugs Sales Market Share by Application in 2020
Figure 46. United States Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Canada Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Mexico Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Brazil Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. APAC Platinum-based Anticancer Drugs Sales Market Share by Region in 2020
Figure 51. APAC Platinum-based Anticancer Drugs Revenue Market Share by Regions in 2020
Figure 52. APAC Platinum-based Anticancer Drugs Sales Market Share by Type in 2020
Figure 53. APAC Platinum-based Anticancer Drugs Sales Market Share by Application in 2020
Figure 54. China Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Japan Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Korea Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Southeast Asia Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. India Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Australia Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Europe Platinum-based Anticancer Drugs Sales Market Share by Country in 2020
Figure 61. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country in 2020
Figure 62. Europe Platinum-based Anticancer Drugs Sales Market Share by Type in 2020
Figure 63. Europe Platinum-based Anticancer Drugs Sales Market Share by Application in 2020
Figure 64. Germany Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. France Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. UK Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Italy Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Russia Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Country in 2020
Figure 70. Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share by Country in 2020
Figure 71. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Type in 2020
Figure 72. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Application in 2020
Figure 73. Egypt Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. South Africa Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Israel Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. Turkey Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 77. GCC Country Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
